Catheter Precision Inc (AMEX:VTAK)’s traded shares stood at 2.23 million during the last session, with the company’s beta value hitting -0.64. At the close of trading, the stock’s price was $0.22, to imply a decrease of -4.34% or -$0.01 in intraday trading. The VTAK share’s 52-week high remains $3.05, putting it -1286.36% down since that peak but still an impressive 27.27% since price per share fell to its 52-week low of $0.16. The company has a valuation of $2.83M, with an average of 2.61 million shares in intraday trading volume over the past 10 days and average of 14.48 million shares over the past 3 months.
Catheter Precision Inc (AMEX:VTAK) trade information
After registering a -4.34% downside in the last session, Catheter Precision Inc (VTAK) has traded red over the past five days. The 5-day price performance for the stock is -0.09%, and -16.49% over 30 days. With these gigs, the year-to-date price performance is -91.67%. Short interest in Catheter Precision Inc (AMEX:VTAK) saw shorts transact 0.44 million shares and set a 0.01 days time to cover.
VTAK Dividends
Catheter Precision Inc has its next earnings report out on 2025-Jul-03. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Catheter Precision Inc (AMEX:VTAK)’s Major holders
Catheter Precision Inc insiders hold 7.99% of total outstanding shares, with institutional holders owning 4.67% of the shares at 5.08% float percentage. In total, 4.67% institutions holds shares in the company.
